- Abstract
- 10.1016/j.jval.2019.09.1787
PND17 SELECTING APPROPRIATE OUTCOME MEASURES FOR ALS CLINICAL TRIALS
- Nov 01, 2019
- Value in Health
- R Arjunji + 5 more +5
Publications from 2021 to 2026
Showing 6 of 6 papers
PND17 SELECTING APPROPRIATE OUTCOME MEASURES FOR ALS CLINICAL TRIALS
P.210Burden of illness of spinal muscular atrophy type 1 (SMA1)
PMU9 DO NICE APPRAISAL PROCESSES REWARD INNOVATIVE AND CURATIVE THERAPIES? AN ASSESSMENT OF CURRENT AND POTENTIAL FUTURE TECHNOLOGY APPRAISALS FOR RARE DISEASES
PSY38 - Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy: A Retrospective Claims Database Analysis
Understanding the Comorbidity Between Dyslexia and Attention-Deficit/Hyperactivity Disorder
Dyslexia and attention-deficit/hyperactivity disorder (ADHD) are 2 of the most prevalent complex neurodevelopmental disorders of childhood, each affecting approximately 5% of the population in the United States. These disorders are also each comorbid with speech sound disorder and language impairment. Understanding the nature of the comorbidity among these disorders could lead to advances in developmental theory, a deeper understanding of the genetic and brain mechanisms that cause disability, a more refined diagnostic classification scheme, and new treatments and interventions for children with these disorders. As part of this special issue of Topics in Language Disorders, this review focuses on the comorbidity between dyslexia and ADHD. It provides a review of the known etiological mechanisms that underlie each disorder. It describes the reconceptualization of these disorders using a multiple deficit model and provides a synopsis of recent studies that illustrate a cohesive approach to investigating the causes of comorbidity. Future directions are discussed in the context of expanding these approaches to the comorbidity among all 4 disorders.
Read moreDiscussion of “Mapping for Changing Environment”